Andrea Dardis Selected Research

Neurologic Manifestations (Neurological Manifestations)

12/2020	In vitro and in vivo effects of Ambroxol chaperone therapy in two Italian patients affected by neuronopathic Gaucher disease and epilepsy.
9/2020	Early biochemical effects of velmanase alfa in a 7-month-old infant with alpha-mannosidosis.
12/2018	The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase.
2/2015	Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C.
7/2012	Early miglustat therapy in infantile Niemann-Pick disease type C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Dardis Research Topics

Disease

15	Glycogen Storage Disease Type II (Pompe's Disease) 04/2023 - 04/2010
12	Gaucher Disease (Gaucher's Disease) 05/2021 - 02/2011
8	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 08/2023 - 07/2012
7	Disease Progression 01/2023 - 04/2010
5	Neurologic Manifestations (Neurological Manifestations) 12/2020 - 07/2012
4	Pain (Aches) 12/2023 - 01/2013
3	Niemann-Pick Diseases (Niemann Pick Disease) 11/2021 - 08/2005
3	Parkinson Disease (Parkinson's Disease) 10/2017 - 07/2014
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 08/2023 - 11/2021
2	alpha-Mannosidosis 01/2023 - 09/2020
2	Lung Diseases (Lung Disease) 12/2021 - 11/2021
2	Splenomegaly 12/2021 - 09/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2020 - 09/2009
2	Tangier Disease 01/2020 - 09/2014
2	Metabolic Diseases (Metabolic Disease) 02/2018 - 01/2014
2	Cognitive Dysfunction 10/2017 - 04/2014
2	Mucopolysaccharidosis II (Hunter Syndrome) 01/2017 - 04/2010
2	Mucolipidoses (Sialidosis) 11/2009 - 06/2009
1	Neuralgia (Stump Neuralgia) 12/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2023
1	Mucopolysaccharidoses 01/2023
1	Neoplasms (Cancer) 01/2021
1	Epilepsy (Aura) 12/2020
1	COVID-19 01/2020
1	Inflammation (Inflammations) 01/2020
1	Nervous System Diseases (Neurological Disorders) 09/2019
1	Muscular Atrophy (Muscle Atrophy) 01/2019
1	Brain Diseases (Brain Disorder) 12/2018
1	Kernicterus 12/2018
1	Neonatal Hyperbilirubinemia 12/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Pancytopenia 09/2014
1	Prurigo 09/2014
1	Lymphedema (Milroy Disease) 09/2014
1	Dysarthria (Spastic Dysarthria) 09/2014
1	Deglutition Disorders (Dysphagia) 09/2014
1	Ataxia (Dyssynergia) 09/2014
1	Muscular Diseases (Myopathy) 08/2014
1	Fabry Disease (Fabry's Disease) 07/2014
1	Late Onset Disorders 06/2014
1	Alzheimer Disease (Alzheimer's Disease) 04/2014
1	Tay-Sachs Disease 05/2012
1	Myalgia 04/2010

Drug/Important Bio-Agent (IBA)

15	AcidsIBA 11/2021 - 08/2005
15	EnzymesIBA 11/2021 - 08/2009
7	alpha-Glucosidases (Acid Maltase)IBA 04/2023 - 12/2010
7	GlucosidasesIBA 12/2020 - 02/2011
6	miglustat (Zavesca)FDA Link 01/2020 - 07/2012
4	GlycosphingolipidsIBA 08/2023 - 09/2009
4	CholesterolIBA 08/2023 - 09/2009
4	Glucosylceramidase (Glucocerebrosidase)IBA 12/2018 - 12/2012
3	GlycogenIBA 04/2023 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2009
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 07/2014
3	Cholinergic Agents (Cholinergics)IBA 09/2019 - 04/2014
2	OligosaccharidesIBA 01/2023 - 09/2020
2	SphingomyelinsIBA 12/2021 - 11/2021
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 11/2021 - 08/2005
2	beta-GlucosidaseIBA 05/2021 - 08/2009
2	RNA Precursors (Precursor, mRNA)IBA 07/2020 - 11/2019
2	Lysosomal Membrane ProteinsIBA 02/2018 - 09/2015
2	HydrolasesIBA 02/2018 - 06/2009
2	Messenger RNA (mRNA)IBA 01/2017 - 09/2009
2	Creatine Kinase (Creatine Phosphokinase)IBA 08/2014 - 04/2010
2	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 04/2010
2	LipidsIBA 07/2014 - 07/2012
1	Medical MarijuanaIBA 12/2023
1	Lysergic Acid Diethylamide (LSD)IBA 08/2023
1	GlycosaminoglycansIBA 01/2023
1	Ambroxol (Mucosolvan)IBA 12/2020
1	alpha-Mannosidase (LAMAN)IBA 09/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2020
1	RNA (Ribonucleic Acid)IBA 07/2020
1	CytokinesIBA 01/2020
1	NucleotidesIBA 11/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Histones (Histone)IBA 12/2018
1	arimoclomolIBA 12/2018
1	BilirubinIBA 12/2018
1	Lysine (L-Lysine)FDA Link 12/2018
1	Iduronic Acid (Iduronate)IBA 01/2017
1	7-ketocholesterolIBA 04/2016
1	eliglustatIBA 01/2016
1	Glucosylceramides (Glucocerebrosides)IBA 01/2016
1	Filipin (Filipin III)IBA 03/2015
1	Glucose (Dextrose)FDA LinkGeneric 03/2015
1	OxysterolsIBA 03/2015
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2014
1	GadoliniumIBA 07/2014
1	alpha-SynucleinIBA 07/2014
1	chitotriosidaseIBA 01/2013
1	Hexosaminidase A (Hex A)IBA 05/2012

Therapy/Procedure

10	Enzyme Replacement Therapy 01/2023 - 12/2010
9	Therapeutics 12/2020 - 10/2003
1	Precision Medicine 08/2023
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Bridge Therapy 01/2023
1	High-Protein Diet 01/2020
1	Enzyme Therapy 01/2017
1	Denervation 01/2017